Professor Shao-Chin Chiang is an esteemed assistant professor at National Yang Ming Chiao Tung University in Taiwan, where he has passionately dedicated nearly seven years to the field of teaching, with a specialized focus on clinical pharmacy. His expertise extends to the intricate realms of cancer pharmacotherapy, hazardous drug handling, and practice management. Beyond academia, he serves as a deputy director at the Koo Foundation Sun Yat-Sen Cancer Center, overseeing the Department of Pharmacy and providing invaluable guidance to young pharmacists. With a multifaceted role that seamlessly blends education and real-world application, Professor Shao-Chin Chiang is a driving force in shaping the future of pharmaceutical care and innovation in Taiwan. 
 

Professor Shao-Chin Chiang's laboratory exemplifies versatility in pharmaceutical research. Beyond its profound engagement with clinical pharmacy, his laboratory extends its reach to the domains of medication reconciliation and biosimilar promotion. Through rigorous research, the lab strives to enhance conventional medication reconciliation processes to align seamlessly with the Taiwan's healthcare systems [1]. Moreover, its inquiry into the benefit-risk equilibrium of biosimilars, particularly from the provider's standpoint, underscores its commitment to providing accessible healthcare services to all. This commitment extends beyond academia, as the lab actively collaborates with industries. For instance, Professor Chiang has developed automated drug compounding machines and continued to validate the quality of prevailing drug transfer system devices used within Taiwanese hospitals [4]. Professor Shao-Chin Chiang's laboratory stands as an embodiment of innovation, collaboration, and resolute pursuit of refining pharmaceutical practices for a brighter future. 

Lab's publications (selected works): 

1. Huang PP, Poon SY, Chang SH, Kuo CW, Chien MW, Chen CC, Chiang SC*. Improving the Efficiency of Medication Reconciliation in Two Taiwanese Hospitals by Using the Taiwan National Health Insurance PharmaCloud Medication System. Int J Gen Med. 2023 Jan 19;16:211-220. 
2. Poon SY, Hsu JC, Ko Y, Chiang SC*. Assessing Knowledge and Attitude of Healthcare Professionals on Biosimilars: A National Survey for Pharmacists and Physicians in Taiwan. Healthcare (Basel). 2021;9(11):1600. 
3. Chen HM, Chen JH, Chiang SC, Lin YC, Ko Y. An evaluation of the healthcare costs of metastatic breast cancer: A retrospective matched cohort study. Medicine. 2021;100(43): e27567. 
4. Chiang SC*, Shen M, Lin CC, Chang HP. Establishing a protocol for the compatibilities of closed-system transfer devices with multiple chemotherapy drugs under simulated clinical conditions. PLoS One. 2021;16(9):e0257873. 
5. Chang LL, Chiang SC, Chiang MK et al. Guideline of Safe Handling for Anti-Neoplastic Hazardous Drugs- 2020. The Journal of Oncology Nursing 2020;20plus:5-76.